Olinvacimab, CAS 2095504-49-5

Product Description: Olinvacimab (TTAC-0001) is a fully human anti-VEGFR2 monoclonal antibody. Olinvacimab inhibits VEGF binds to KDR with a Kd value of 0.23 nM. Olinvacimab has antiangiogenic activity. Olinvacimab can be used for the research of recurrent glioblastoma and breast cancer[1].

Applications: Cancer-Kinase/protease

Formula: N/A

References: [1]Lee WS, et al. TTAC-0001, a human monoclonal antibody targeting VEGFR-2/KDR, blocks tumor angiogenesis. MAbs. 2015;7(5):957-68.

CAS Number: 2095504-49-5

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: VEGFR

• SKU: MEXHY-P99768-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99768-10
• Package Unit: 10 mg
• Quantity Unit: STK
• Conjugate: Unconjugated